Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Industry-Sponsored Trials More Widely Cited Than Not-for-Profit Studies
Link ID 8563
Title Industry-Sponsored Trials More Widely Cited Than Not-for-Profit Studies
Url http://www.medscape.com/viewarticle/580356?src=rss
Description With high-quality research performed by federally funded investigators, efforts should be made to ensure these important trials are more widely disseminated to the cardiovascular community, researchers report. Heartwire
Category Articles > Business of Medicine
Keywords
Date Sep 11, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Delivery of Care in Resource-Limited Countries
  New data on the delivery of care in resource-limited countries were presented at the AIDS 2008: XVII International AIDS Conference held August 3-8, 2008, in Mexico City, Mexico.
Medscape HIV/AIDS
Category:   Articles > Business of Medicine


2. Are Osteoporosis Risks Being Overlooked?
  Missed opportunities for osteoporosis detection and treatment following fractures are common.
Medscape Pharmacists
Category:   Articles > Business of Medicine


3. Cases From AHRQ WebM&M: Copy and Paste
  Copying from an electronic record saves time--but can it endanger your patient? Agency for Healthcare Research and Quality (AHRQ)
Category:   Articles > Business of Medicine


4. Health Net Profit Rises, but Forecast Is Weak
  Insurer Health Net Inc posted a 46 percent rise in quarterly profit Tuesday, helped by its Medicare plans for older Americans, but forecast 2008 earnings below Wall Street expectations. Reuters Health Information
Category:   Articles > Business of Medicine


5. FDA Warns Bayer About "Unlawful" Marketing of Aspirin-Supplement Combinations
  An aspirin-calcium combination marketed for women and an aspirin-phytosterol combination that purports to reduce heart-disease risk are illegal, the FDA says. Bayer, in response, says it "stands behind" its claims but is working with the FDA. Heartwire
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS